Form 8-K · Current Report · Filed 2026-09-10
Elevance Health Reaffirms 2026 Earnings Guidance
Elevance Health, Inc. has reaffirmed its shareholders' earnings guidance for full year 2026 to be at least $20.10 per diluted share, including approximately $6.90 per diluted share of net unfavorable items. Excluding these items, the Company continues to expect adjusted shareholders' earnings to be at least $27.00 per diluted share. The Company also reaffirmed its full year 2026 benefit expense ratio guidance of 90.2% plus or minus 50 basis points.
- Filer
- Elevance Health Inc. ELV · NYSE
- Filed
- Accession
- 0001156039-26-000063
- CIK
- 0001156039
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$396.90
Since filing
+0.0%
Latest close
$396.90
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from ELV reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, ELV insiders reported 3 Form 4 transactions — net selling of $202K.
About Elevance Health Inc.
Elevance Health Inc., formerly known as Anthem, is a prominent health insurance company in the United States. Its primary function is to provide a wide range of health insurance products and related services to a diverse customer base, including individuals, families, and businesses. Elevance Health focuses on enhancing health and well-being by offering managed care plans tailored to the varying needs of its clients. With a robust portfolio, Elevance Health caters to multiple sectors within the healthcare industry, influencing stakeholders such as healthcare providers, pharmaceutical companies, and medical technology firms. The company plays a critical role in the healthcare market by negotiating coverage terms, managing costs, and ensuring policyholders have access to necessary medical services. As one of the largest health insurers in the nation, Elevance Health holds significant market influence, contributing to shaping healthcare policies and practices through its vast network and strategic partnerships. By leveraging technology and data analytics, the company aims to improve patient outcomes, streamline insurance processes, and foster advancements in personalized healthcare solutions.
Never miss another ELV filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.